Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05764720 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach

Study acronym: ARTIA-Pancreas
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 3 to 4v7
  2. Primary completion date: Feb 15, 2026 to Mar 2028
    • Study sites: 2 to 3
    • Study completion date: Feb 15, 2028 to Mar 15, 2030
    v6
  3. Re-verified, no change to tracked fieldsv5
  4. Study sites: 1 to 2v4
  5. Primary completion date: Feb 15, 2025 to Feb 15, 2026
    • Study completion date: Feb 15, 2027 to Feb 15, 2028
    v3
  6. Start date changed from estimate of Mar 14, 2023 to May 14, 2023
    • Site contact updated
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This trial is a single-arm, prospective, multi-center clinical trial designed to demonstrate that stereotactic adaptive radiotherapy using an ablatively dosed (50Gy,5fx) for treatment of borderline-resectable, locally-advanced , or medically inoperable pancreatic adenocarcinoma will translate into a decreased toxicity. The study will evaluate GI toxicity, overall survival, local control, quality of life, and workflow metrics.
Trial Details
NCT Number NCT05764720
Lead Sponsor Varian, a Siemens Healthineers Company
Collaborators: Washington University School of Medicine
Conditions
(from sponsor)		 Pancreatic Cancer
Related terms Pancreatic Neoplasms
Enrollment 134 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov